These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23220563)

  • 21. CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy.
    Pelissier A; Bonneau C; Chéreau E; de La Motte Rouge T; Fourchotte V; Daraï E; Rouzier R
    Gynecol Oncol; 2014 Dec; 135(3):542-6. PubMed ID: 25223808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel index for preoperative, non-invasive prediction of macro-radical primary surgery in patients with stage IIIC-IV ovarian cancer-a part of the Danish prospective pelvic mass study.
    Karlsen MA; Fagö-Olsen C; Høgdall E; Schnack TH; Christensen IJ; Nedergaard L; Lundvall L; Lydolph MC; Engelholm SA; Høgdall C
    Tumour Biol; 2016 Sep; 37(9):12619-12626. PubMed ID: 27440204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction.
    Sood AK; Sorosky JI; Gelder MS; Buller RE; Anderson B; Wilkinson EJ; Benda JA; Morgan LS
    Cancer; 1998 May; 82(9):1731-7. PubMed ID: 9576296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management.
    Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S
    Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.
    Moore RG; Brown AK; Miller MC; Skates S; Allard WJ; Verch T; Steinhoff M; Messerlian G; DiSilvestro P; Granai CO; Bast RC
    Gynecol Oncol; 2008 Feb; 108(2):402-8. PubMed ID: 18061248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of human epididymis protein 4 in predicting cytoreductive surgical outcomes for advanced ovarian tubal and peritoneal carcinoma.
    Tang Z; Chang X; Ye X; Li Y; Cheng H; Cui H
    Chin J Cancer Res; 2015 Jun; 27(3):309-17. PubMed ID: 26157328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proofs for implementation of higher HE4 and ROMA index cut-off values in ovarian cancer preoperative stratification.
    Špacir Prskalo Z; Bulić P; Langer S; Gaće M; Puljiz M; Danolić D; Alvir I; Mamić I; Šušnjar L; Mayer L
    J Obstet Gynaecol; 2019 Feb; 39(2):195-201. PubMed ID: 30207507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can the preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? A single institution cohort study.
    Vorgias G; Iavazzo C; Savvopoulos P; Myriokefalitaki E; Katsoulis M; Kalinoglou N; Akrivos T
    Gynecol Oncol; 2009 Jan; 112(1):11-5. PubMed ID: 19119502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with cytoreducibility among women with ovarian carcinoma.
    Eltabbakh GH; Mount SL; Beatty B; Simmons-Arnold L; Cooper K; Morgan A
    Gynecol Oncol; 2004 Nov; 95(2):377-83. PubMed ID: 15491760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative serum level of CA153 and a new model to predict the sub-optimal primary debulking surgery in patients with advanced epithelial ovarian cancer.
    Jia Y; Jiang Y; Fan X; Zhang Y; Li K; Wang H; Ning X; Yang X
    World J Surg Oncol; 2024 Feb; 22(1):64. PubMed ID: 38395933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic value of serum CA(125) level change during chemotherapy post-surgery in patients with advanced epithelial ovarian carcinoma].
    Lan CY; Huang H; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):732-6. PubMed ID: 19087537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer.
    Gemer O; Lurian M; Gdalevich M; Kapustian V; Piura E; Schneider D; Lavie O; Levy T; Fishman A; Dgani R; Levavi H; Beller U
    Eur J Surg Oncol; 2005 Nov; 31(9):1006-10. PubMed ID: 16005601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score.
    Brun JL; Rouzier R; Uzan S; Daraï E
    Gynecol Oncol; 2008 Sep; 110(3):354-9. PubMed ID: 18572226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Onkologie; 2008 Jun; 31(6):315-20. PubMed ID: 18547972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer.
    Nakae M; Iwamoto I; Fujino T; Maehata Y; Togami S; Yoshinaga M; Douchi T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):309-14. PubMed ID: 16764622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Advanced ovarian cancer: criteria of resectability].
    Chéreau E; Ballester M; Rouzier R; Coutant C; Daraï E
    Bull Cancer; 2009 Dec; 96(12):1189-97. PubMed ID: 19919915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study.
    Eisenkop SM; Friedman RL; Wang HJ
    Gynecol Oncol; 1998 May; 69(2):103-8. PubMed ID: 9600815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic open laparoscopy in the management of advanced ovarian cancer.
    Angioli R; Palaia I; Zullo MA; Muzii L; Manci N; Calcagno M; Panici PB
    Gynecol Oncol; 2006 Mar; 100(3):455-61. PubMed ID: 16325244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study.
    Braicu EI; Fotopoulou C; Van Gorp T; Richter R; Chekerov R; Hall C; Butz H; Castillo-Tong DC; Mahner S; Zeillinger R; Concin N; Vergote I; Sehouli J
    Gynecol Oncol; 2013 Feb; 128(2):245-51. PubMed ID: 23178313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue polypeptide specific antigen and cancer associated serum antigen in the follow-up of ovarian cancer.
    Sliutz G; Tempfer C; Kainz C; Mustafa G; Gitsch G; Koelbl H; Biegelmayer C
    Anticancer Res; 1995; 15(3):1127-9. PubMed ID: 7645936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.